CH

Chemed Corporation

CHEHealthcareNASDAQ

Medical Care Facilities · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$2.53B
+4.1% YoY
Net Income
$265.2M
-12.2% YoY
EBITDA
$422.4M
-9.0% YoY
Free Cash Flow
$348.3M

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 78.2, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 79.9, above 70, stock may be overbought
About Chemed Corporation

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers. With a market capitalization of $6.77B, it sits in mid-cap territory. The company operates through two segments: VITAS and Roto-Rooter segments.

Key stats
Market Cap$6.77B
P/E (TTM)27.39
Fwd P/E18.97
EPS$18.62
Beta0.52
52W Change+13.0%
Dividend Yield0.48%
ROE25.6%
Analysis

The company holds $16.9M in cash, though total debt stands at $236.9M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $348.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 25.6% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 12.8% further supports the picture of efficient asset utilization. Revenue has been uneven over recent years, ranging from $2.14B to $2.53B.

With a beta below 0.7, Chemed Corporation typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. No single metric tells the full story. Reviewing CHE's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms